Back
Myriad Genetics Quote, Financials, Valuation and Earnings
Sponsored
MYGN
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
MYGN
Myriad Genetics
Last Price:
14.97
Seasonality Move:
18.24%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Myriad Genetics Price Quote
$14.97
-0.33 (-2.16%)
(Updated: November 21, 2024 at 3:05 PM ET)
Myriad Genetics Key Stats
Sell
16
Myriad Genetics (MYGN)
is a Sell
Day range:
$14.72 - $15.33
52-week range:
$14.91 - $29.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.65
P/B ratio:
1.89%
Volume:
687.1K
Avg. volume:
914.4K
1-year change:
-15.28%
Market cap:
$1.4B
Revenue:
$753.2M
EPS:
$-1.3
How Much Does Myriad Genetics Make?
-
How Much Are Myriad Genetics's Sales Annually?
MYGN Revenues are $753.2M -
How Much Profit Does Myriad Genetics's Make A Year?
MYGN net income is -$263.3M
Is Myriad Genetics Growing As A Company?
-
What Is Myriad Genetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.11% -
What Is Myriad Genetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Myriad Genetics Stock Price Performance
-
Did Myriad Genetics Stock Go Up Last Month?
Myriad Genetics share price went down by -34.59% last month -
Did MYGN's Share Price Rise Over The Last Year?
MYGN share price fell by -15.28% over the past 1 year
What Is Myriad Genetics 52-Week High & Low?
-
What Is Myriad Genetics’s 52-Week High Share Price?
Myriad Genetics has traded as high as $29.30 over the past 52 weeks -
What Is Myriad Genetics’s 52-Week Low Share Price?
Myriad Genetics has traded as low as $14.91 over the past 52 weeks
Myriad Genetics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Myriad Genetics?
-
How Much Debt Does Myriad Genetics Have?
Total long term debt quarterly is $39M -
How Much Cash Does Myriad Genetics Have?
Cash and short term investments quarterly total is $99.9M -
What Is Myriad Genetics’s Book Value Per Share?
Book value per share is 8.04
Is Myriad Genetics Cash Flow Positive?
-
What Is MYGN Cash Flow From Operations?
Cash flow from operations (TTM) is -$70M -
What Is Myriad Genetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $112.4M -
What Is Myriad Genetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$18M
Myriad Genetics Return On Invested Capital
-
Is Management Doing A Good Job?
MYGN return on invested capital is -14.9% -
What Is Myriad Genetics Return On Assets?
ROA measures how assets are converting to revenues and is -10.41% -
What Is MYGN Return On Equity?
ROE is a measure of profitability and is -15.68%
Myriad Genetics Earnings Date & Stock Price
-
What Is Myriad Genetics's Stock Price Today?
A single share of MYGN can be purchased today for 15.30 -
What Is Myriad Genetics’s Stock Symbol?
Myriad Genetics trades on the nasdaq under the ticker symbol: MYGN -
When Is Myriad Genetics’s Next Earnings Date?
The next quarterly earnings date for Myriad Genetics is scheduled on February 27, 2025 -
When Is MYGN's next ex-dividend date?
Myriad Genetics's next ex-dividend date is May 26, 2020 -
How To Buy Myriad Genetics Stock?
You can buy Myriad Genetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Myriad Genetics Competitors
-
Who Are Myriad Genetics's Competitors?
Below is a list of companies who compete with Myriad Genetics or are related in some way:
Myriad Genetics Dividend Yield
-
What Is MYGN Dividend Yield?
Myriad Genetics’s dividend yield currently is 0% -
What Is Myriad Genetics’s Payout Ratio?
Myriad Genetics’s payout ratio is 0% -
When Did Myriad Genetics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Myriad Genetics’s Dividend Per Share?
Myriad Genetics pays a dividend of $0.00 per share
Myriad Genetics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 211.04% |
Revenue: | 11.15% | 1.19% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 1 |
Price Target: | 24.08 |
Upside from Last Price: | 57.37% |